~107 spots leftby Jun 2026

FOCUS ON US Program for Cancer Patients

Recruiting in Palo Alto (17 mi)
+1 other location
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Charles Kamen
No Placebo Group

Trial Summary

What is the purpose of this trial?

Our aim for this study is to assess the feasibility and acceptability and explore potential outcomes of the adapted FOCUS On Us intervention in a two-arm pilot trial. The investigators will randomize 80 sexual and/or gender minority (SGM; e.g., lesbian, gay, bisexual, transgender, queer, etc.) cancer patients and their ≥80 informal caregivers (total N≥160) to either FOCUS On Us (adapted from the evidence-based FOCUS program) or a waitlist control.

Research Team

Eligibility Criteria

This trial is for sexual and/or gender minority (SGM) cancer patients, such as those who identify as lesbian, gay, bisexual, transgender, queer etc., along with their informal caregivers. A total of at least 160 participants will be involved.

Inclusion Criteria

I am 18 years old or older.
Patients must live in the United States
I am a caregiver and identify as part of the SGM community or support someone who does.
See 11 more

Treatment Details

Interventions

  • FOCUS ON US (Behavioral Intervention)
Trial OverviewThe study tests the adapted FOCUS On Us program against a waitlist control in a two-arm pilot trial to see if it's feasible and acceptable for SGM cancer patients and their caregivers.
Participant Groups
2Treatment groups
Active Control
Group I: InterventionActive Control1 Intervention
This group will complete a baseline assessment and then receive the intervention immediately. Participants will complete a post-intervention assessment survey after completing the intervention. Finally, participants will be contacted for a follow-up assessment 3 months after finishing the intervention.
Group II: Waitlist ControlActive Control1 Intervention
This group will create a baseline assessment and will not receive the intervention. Participants will complete a post-intervention assessment survey \~3 months after baseline. Following a \~6-month (from baseline) follow-up assessment, this group will be offered the intervention.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
University Of RochesterRochester, NY
Wayne State UniversityDetroit, MI
Loading ...

Who Is Running the Clinical Trial?

Charles Kamen

Lead Sponsor

Trials
1
Patients Recruited
160+

Wayne State University

Collaborator

Trials
318
Patients Recruited
111,000+

National Cancer Institute (NCI)

Collaborator

Trials
14080
Patients Recruited
41,180,000+